{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:02:14Z","timestamp":1785420134615,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP17K16665"],"award-info":[{"award-number":["JP17K16665"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bbrc.2020.01.148","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T07:52:16Z","timestamp":1580889136000},"page":"723-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells"],"prefix":"10.1016","volume":"524","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8142-4870","authenticated-orcid":false,"given":"Yoshinari","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-9277","authenticated-orcid":false,"given":"Shun","family":"Yamamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Tatsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Hanashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodai","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0673-6556","authenticated-orcid":false,"given":"Atsuo","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.01.148_bib1","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0909-1010","article-title":"Cancer stem cells: mirage or reality?","volume":"15","author":"Gupta","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.01.148_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.148_bib3","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-13-0109","article-title":"Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma","volume":"73","author":"Natsume","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib4","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1158\/1078-0432.CCR-14-0832","article-title":"Immunotherapy for primary brain tumors: no longer a matter of privilege","volume":"20","author":"Fecci","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2020.01.148_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.01.148_bib7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3171\/2015.5.JNS141901","article-title":"Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model","volume":"124","author":"Hanihara","year":"2016","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.bbrc.2020.01.148_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Muller","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.01.148_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.01.148_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI21583","article-title":"Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes","volume":"114","author":"Munn","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2020.01.148_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3171\/2008.10.JNS081141","article-title":"Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy: laboratory investigation","volume":"111","author":"Miyazaki","year":"2009","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.bbrc.2020.01.148_bib12","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against Ido, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1227\/NEU.0b013e31828cf945","article-title":"Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas","volume":"72","author":"Mitsuka","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbrc.2020.01.148_bib14","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1158\/1078-0432.CCR-18-0041","article-title":"Tryptophan metabolism contributes to radiation- induced immune checkpoint reactivation in glioblastoma","volume":"24","author":"Kesarwani","year":"2018","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/ijo.2015.2992","article-title":"Characterization of glioma stem-like cells from human glioblastomas","volume":"47","author":"Yamamuro","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2020.01.148_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2009.04.020","article-title":"Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling","volume":"284","author":"Yuki","year":"2009","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2020.01.148_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3892\/ijo_00000322","article-title":"Effect of IFN-beta on human glioma cell lines with temozolomide resistance","volume":"35","author":"Yoshino","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2020.01.148_bib18","first-page":"529","article-title":"Gene expression profiles predicting the response to IFN-beta and a combination of temozolomide and IFN-beta in malignant gliomas","volume":"39","author":"Yoshino","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2020.01.148_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2009.01.016","article-title":"Isolation and characterization of cancer stem like cells in human glioblastoma cell lines","volume":"279","author":"Qiang","year":"2009","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2020.01.148_bib20","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mod.2004.08.008","article-title":"Pluripotential competence of cells associated with Nanog activity","volume":"122","author":"Hatano","year":"2005","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbrc.2020.01.148_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(03)00393-3","article-title":"The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells","volume":"30","author":"Mitsui","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.148_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2020.01.148_bib24","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3892\/ijo.2015.3165","article-title":"Antitumorigenic effect of interferon-beta by inhibition of undifferentiated glioblastoma cells","volume":"47","author":"Yamamuro","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2020.01.148_bib25","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","article-title":"Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives","volume":"17","author":"Godin-Ethier","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/vaccines3030703","article-title":"The role of indoleamine 2,3-dioxygenase in immune suppression and autoimmunity","volume":"3","author":"Mbongue","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.bbrc.2020.01.148_bib27","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond Ido and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib28","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2020.01.148_bib29","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1128\/JVI.00792-07","article-title":"Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response","volume":"81","author":"Suh","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.01.148_bib30","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/IAI.05021-11","article-title":"Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells","volume":"79","author":"Li","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2020.01.148_bib31","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1158\/0008-5472.CAN-05-0036","article-title":"IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide","volume":"65","author":"Natsume","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2020.01.148_bib32","first-page":"1253","article-title":"Potentiation of antiglioma effect with combined temozolomide and interferon-\u00df","volume":"16","author":"Park","year":"2006","journal-title":"Oncol. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2030231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2030231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:47:11Z","timestamp":1757764031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2030231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0006291X2030231X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.148","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}